DE69130696D1 - Ein neues, biologisch aktives vom Huhn stammendes Peptid (Huhn-CNP) - Google Patents

Ein neues, biologisch aktives vom Huhn stammendes Peptid (Huhn-CNP)

Info

Publication number
DE69130696D1
DE69130696D1 DE69130696T DE69130696T DE69130696D1 DE 69130696 D1 DE69130696 D1 DE 69130696D1 DE 69130696 T DE69130696 T DE 69130696T DE 69130696 T DE69130696 T DE 69130696T DE 69130696 D1 DE69130696 D1 DE 69130696D1
Authority
DE
Germany
Prior art keywords
chicken
new
biologically active
peptide
cnp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69130696T
Other languages
English (en)
Other versions
DE69130696T2 (de
Inventor
Hisayuki Matsuo
Kenji Kangawa
Naoto Minamino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MATSUO, HISAYUKI, KOBE, HYOGO, JP
Asubio Pharma Co Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE69130696D1 publication Critical patent/DE69130696D1/de
Publication of DE69130696T2 publication Critical patent/DE69130696T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69130696T 1990-09-07 1991-09-06 Ein neues, biologisch aktives vom Huhn stammendes Peptid (Huhn-CNP) Expired - Fee Related DE69130696T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2238293A JP2977158B2 (ja) 1990-09-07 1990-09-07 トリ由来新規生理活性ペプチド（ニワトリｃｎｐ）

Publications (2)

Publication Number Publication Date
DE69130696D1 true DE69130696D1 (de) 1999-02-11
DE69130696T2 DE69130696T2 (de) 1999-06-10

Family

ID=17028039

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130696T Expired - Fee Related DE69130696T2 (de) 1990-09-07 1991-09-06 Ein neues, biologisch aktives vom Huhn stammendes Peptid (Huhn-CNP)

Country Status (8)

Country Link
US (1) US5338830A (de)
EP (1) EP0475291B1 (de)
JP (1) JP2977158B2 (de)
AT (1) ATE175210T1 (de)
DE (1) DE69130696T2 (de)
DK (1) DK0475291T3 (de)
ES (1) ES2127190T3 (de)
GR (1) GR3029628T3 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0203172B8 (pt) 2001-09-28 2021-05-25 Nakao Kazuwa composição farmacêutica para acondroplasia
WO2005094890A1 (ja) 2004-03-31 2005-10-13 Kazuwa Nakao 身長増加用組成物
WO2005094889A1 (ja) 2004-03-31 2005-10-13 Chugai Seiyaku Kabushiki Kaisha 関節炎症治療剤又は予防剤
ES2687786T3 (es) 2004-04-21 2018-10-29 Alexion Pharmaceuticals, Inc. Conjugados para administración ósea y procedimiento de uso de estos para dirigir proteínas al hueso
EP2658979B1 (de) 2010-12-27 2018-02-14 Alexion Pharmaceuticals, Inc. Zusammensetzungen mit natriuretischen peptiden und verwendungsverfahren dafür
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10822596B2 (en) 2014-07-11 2020-11-03 Alexion Pharmaceuticals, Inc. Compositions and methods for treating craniosynostosis
US10449236B2 (en) 2014-12-05 2019-10-22 Alexion Pharmaceuticals, Inc. Treating seizure with recombinant alkaline phosphatase
US10603361B2 (en) 2015-01-28 2020-03-31 Alexion Pharmaceuticals, Inc. Methods of treating a subject with an alkaline phosphatase deficiency
JP7253220B2 (ja) * 2015-07-31 2023-04-06 株式会社 イギス Ｃｎｐ環状ペプチド並びに該環状ペプチドを含む医薬品、外用剤および化粧料
RU2745528C2 (ru) 2015-08-17 2021-03-26 Алексион Фармасьютикалз, Инк. Производство щелочных фосфатаз
WO2017058822A1 (en) 2015-09-28 2017-04-06 Alexion Pharmaceuticals, Inc. Identifying effective dosage regimens for tissue non-specific alkaline phosphatase (tnsalp)-enzyme replacement therapy of hypophosphatasia
EP3368062A4 (de) 2015-10-30 2019-07-03 Alexion Pharmaceuticals, Inc. Verfahren zur behandlung von craniosynostose bei einem patienten
WO2017155569A1 (en) 2016-03-08 2017-09-14 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
EP3436020A4 (de) 2016-04-01 2019-12-25 Alexion Pharmaceuticals, Inc. Verfahren zur behandlung von hypophosphatasie bei jugendlichen und erwachsenen
KR20220162816A (ko) 2016-04-01 2022-12-08 알렉시온 파마슈티칼스, 인코포레이티드 알칼리성 포스파타아제로 근육 약화의 치료
WO2017214130A1 (en) 2016-06-06 2017-12-14 Alexion Pharmaceuticals, Inc. Metal impact on manufacturing of alkaline phosphatases
JP7018933B2 (ja) 2016-08-18 2022-02-14 アレクシオン ファーマシューティカルズ， インコーポレイテッド 気管気管支軟化症の治療方法
MX2019011508A (es) 2017-03-31 2019-11-01 Alexion Pharma Inc Metodos para tratar la hipofosfatasia (hpp) en adultos y adolescentes.
US11913039B2 (en) 2018-03-30 2024-02-27 Alexion Pharmaceuticals, Inc. Method for producing recombinant alkaline phosphatase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2544929B2 (ja) * 1987-06-17 1996-10-16 第一化学薬品 株式会社 新規生理活性ペプチド
US5114923A (en) * 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides

Also Published As

Publication number Publication date
DE69130696T2 (de) 1999-06-10
US5338830A (en) 1994-08-16
JPH04120094A (ja) 1992-04-21
DK0475291T3 (da) 1999-08-30
GR3029628T3 (en) 1999-06-30
JP2977158B2 (ja) 1999-11-10
ATE175210T1 (de) 1999-01-15
ES2127190T3 (es) 1999-04-16
EP0475291A1 (de) 1992-03-18
EP0475291B1 (de) 1998-12-30

Similar Documents

Publication Publication Date Title
DE69130696D1 (de) Ein neues, biologisch aktives vom Huhn stammendes Peptid (Huhn-CNP)
DE69130695T2 (de) Neues, biologisch aktives, vom Frosch stammendes Peptid (Frosch-CNP)
DE59304248D1 (de) Mehrstufenprozess zur Herstellung von thermoplastisch verarbeitbaren Polyurethan-Elastomeren
DE68921850D1 (de) Reinigung von durch Verwendung von Doppelmetallcyanidkomplexkatalysatoren hergestellten Polyolen.
DE69128754T2 (de) Merschliches CNP-Gen und Vorläufer protein
DK0696937T3 (da) Fremgangsmåde til behandling af spontant forbrændelige katalysatorer
NO885275L (no) Vaskulaere antikoagulantproteiner, dna'er som koder for dem, fremstilling og anvendelse derav.
ATE39249T1 (de) Verfahren zur herstellung von polyisocyanatopolyisocyanuraten durch katalytische cyclotrimerisierung von polyisocyanaten.
NO895028L (no) Ny chimerisk transformerende vekstfaktor-beta.
ATE152734T1 (de) Bpc-peptide, deren herstellung und verwendung
DE69010171D1 (de) Mehrstufenverfahren zur Herstellung von Hexafluoropropylen.
DE3853446D1 (de) Fibronectinbindungsprotein und dessen Herstellung.
DE59102062D1 (de) Verfahren zur biologischen Reinigung von Abluftströmen.
DE59308152D1 (de) Mehrstufenprozess zur Herstellung von thermoplastisch verarbeitbaren Polyurethan-Elastomeren
DE3873342T3 (de) Nicht-zylindrischer reaktor zur herstellung von furnace-russ.
ATE305044T1 (de) Lgmd- gen kodierend für einer calcium abhängigen protease
ATE94588T1 (de) Verfahren zur herstellung und reinigung von alpha-interferon.
ATE47880T1 (de) Vorlaeufer eines an dem c-ende amidierten peptids und dessen herstellung.
DE69116803D1 (de) Peroxidase-Gen von mikrobischem Ursprung
ATE81013T1 (de) Verfahren zur herstellung von faktor viii:cmangelplasma und ein so erhaltenes mangelplasma.
DE59008482D1 (de) Verfahren zur Herstellung von 2,4,5-Triamino-6-hydroxypyrimidin durch katalytische Hydrierung von 2,4-Diamino-6-hydroxy-5-nitrosopyrimidin.
DE68910033D1 (de) Katalytisches Verfahren zur Herstellung von optisch-aktiven Alpha-Hydroxycarboxylaten.
DE69105885D1 (de) Katalytisches Verfahren zur Herstellung von sec-Butylbenzol.
ATE102997T1 (de) Thymosin und tnf-kodierende dna.
DE69206116D1 (de) Verfahren zur Reinigung von 1,1-Dichlor-1-Fluorethan.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP

Owner name: MATSUO, HISAYUKI, KOBE, HYOGO, JP

8339 Ceased/non-payment of the annual fee